Efficacy and tolerability of lenalidomide (LEN) in patients (pts) 75 and older versus those younger than 75 with RBC transfusion-dependent low/int-1-risk MDS and del 5q Fenaux, P., Guerci-Bresler, A., Muus, P., Sekeres, M. A., Giagounidis, A., Deeg, H., Greenberg, P., Skikne, B., Yu, X., List, A. F. AMER SOC CLINICAL ONCOLOGY. 2012

View details for Web of Science ID 000318009802797